- Home
- FGL vs ENLV Comparison
FGL vs ENLV Comparison
Compare FGL & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- ENLV
- Stock Information
- Founded
- FGL 2021
- ENLV 2005
- Country
- FGL Malaysia
- ENLV Israel
- Employees
- FGL N/A
- ENLV N/A
- Industry
- FGL
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- ENLV Health Care
- Exchange
- FGL NYSE
- ENLV Nasdaq
- Market Cap
- FGL 22.5M
- ENLV 20.7M
- IPO Year
- FGL 2024
- ENLV 1995
- Fundamental
- Price
- FGL $1.38
- ENLV $1.01
- Analyst Decision
- FGL
- ENLV Strong Buy
- Analyst Count
- FGL 0
- ENLV 2
- Target Price
- FGL N/A
- ENLV $10.00
- AVG Volume (30 Days)
- FGL 66.4K
- ENLV 146.1K
- Earning Date
- FGL 12-17-2024
- ENLV 04-11-2025
- Dividend Yield
- FGL N/A
- ENLV N/A
- EPS Growth
- FGL 45.69
- ENLV N/A
- EPS
- FGL 0.04
- ENLV N/A
- Revenue
- FGL $23,268,519.00
- ENLV N/A
- Revenue This Year
- FGL N/A
- ENLV N/A
- Revenue Next Year
- FGL N/A
- ENLV N/A
- P/E Ratio
- FGL $36.30
- ENLV N/A
- Revenue Growth
- FGL 336.06
- ENLV N/A
- 52 Week Low
- FGL $1.21
- ENLV $0.81
- 52 Week High
- FGL $5.26
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- ENLV 44.89
- Support Level
- FGL N/A
- ENLV $0.92
- Resistance Level
- FGL N/A
- ENLV $1.13
- Average True Range (ATR)
- FGL 0.00
- ENLV 0.10
- MACD
- FGL 0.00
- ENLV -0.01
- Stochastic Oscillator
- FGL 0.00
- ENLV 24.32
About FGL FOUNDER GROUP LTD
Founder Group Ltd acts as an end-to-end Engineering, Procurement, Construction, and Commissioning solutions provider for solar PV facilities in Malaysia. The segments of the company are large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects of the company are utility-scale solar PV power plants with installed generating capacity of 1 MWac or more, and C&I projects of the company are smaller-scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their consumption at factories, warehouses, and commercial stores. The company derives its revenue from Malaysia.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.